Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients
PHASE2CompletedINTERVENTIONAL
Enrollment
50
Participants
Timeline
Start Date
April 30, 2015
Primary Completion Date
May 31, 2016
Study Completion Date
May 31, 2016
Conditions
Clinically Diagnosed Endometriotic Patient Was Defined as a Woman Who Has Pelvic Pain and at Least One Evidence of PV or TVS
Interventions
DRUG
Depot medroxyprogesterone acetate
DEVICE
LNG-IUS
All Listed Sponsors
lead
Chulalongkorn University
OTHER
NCT02894151 - Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients | Biotech Hunter | Biotech Hunter